CHARLOTTE, N.C.—Microban International Ltd. said its Microban Medical silver antimicrobial technology high-consistency rubber silicone is engineered to meet stricter FDA guidelines.
The company said it recently conducted in vitro testing designed to simulate planktonic and biofilm growth on high-consistency rubber silicone, which is commonly used in the manufacture of urinary catheters.
Urinary infections are a costly source of hospital-acquired infections, and current technologies have had limited success in reducing infection rates, Microban said.
Initial results for the Microban technology exceed FDA guidelines and surpassed unprotected HCR silicone.
In addition, Microban microbiologists assessed the impact of Microban silver technology on biofilm formation.
For detailed in vitro study results on Microban silver antimicrobial technology, visit http://info.microban.com/HCRsilicone.html.